(Q27860831)

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Self-renewal and cancer of the gut: two sides of a coin.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Guidelines 2000 for colon and rectal cancer surgery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Breast cancer stem cells revealed

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Cancer stem cells: lessons from leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

THE EFFICIENT DESIGN OF TRANSPLANTABLE TUMOUR ASSAYS.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Self-renewal and solid tumor stem cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Roots and stems: stem cells in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Therapeutic implications of cancer stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE05372

7 January 2021

Identifiers

DOI

10.1038/NATURE05372

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

212783

1002972347

0 references

212783

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference